Navigation Links
InVitria's Cellastim Delivers Superior Results in Mammalian Cell Culture
Date:9/25/2008

FORT COLLINS, Colo., Sept. 25 /PRNewswire/ -- Steve Pettit, Director of the company's Cell Culture Group, presented results of InVitria's (http://www.InVitria.com) Cellastim in mammalian cell culture at the 2008 BioProcess International Conference in Anaheim, California this week.

"Cellastim showed superior results compared to other sources of albumin and delivered an average of 50% improvement in productivity in CHO cell lines using variety of the leading chemically defined and animal free medias sold in the US," said Dr. Steve Pettit, Director of InVitria's Cell Culture Group.

Studies support InVitria's claim that its Cellastim product, an animal free recombinant human serum albumin, outperforms other chemically defined cell culture ingredients and is gaining acceptance by the biopharmaceutical industry as a supplement for cell culture media. Cellastim is a defined supplement that can enhance performance of chemically-defined media.

Additionally, InVitria's Lacromin product, which is an animal free recombinant lactoferrin, has proven to be a strong growth factor while simultaneously enhancing productivity across many cell lines.

"We continue to show powerful results of Cellastim and Lacromin in cell culture media for a variety of cell lines including CHO, Hybridoma, Vero and NS0 cells. Since these are well defined supplements, they help our customers achieve both their regulatory and manufacturing goals. These are the only supplements available that not only improve cell culture performance, but do this while maintaining a defined and animal free media," said Scott Deeter, InVitria's President.

To obtain a copy of Dr. Pettit's presentation please contact InVitria by phone or email at:
1-800-916-8311

info@InVitria.com

About InVitria (http://www.InVitria.com)

InVitria has developed animal free cell culture ingredients that enhance productivity, safety and time to market for companies in the biopharmaceutical, cell culture, life science research and diagnostics industry.


'/>"/>
SOURCE InVitria
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade.
2. New Turbomolecular Pumping System From Varian, Inc. Delivers Portable, Dry, Ultra-high Vacuum.
3. Core Informatics Delivers Enterprise Core LIMS Installation to BioRelix Pharmaceuticals
4. NIOXIN(R) Delivers the Future to Scalp and Hair Care, Introduces the First Genetic Test to Determine the Likelihood of Hair Loss
5. Millennium Over-Delivers on 2007 Goals and Financial Guidance
6. Nikon Instruments New NIS-Elements C Delivers Comprehensive Confocal and Widefield Imaging Capabilities in Single Unifying Software Platform
7. CompareNetworks Media Group Delivers CME/CE Through Acuity Medical Education
8. Superior Patient Clinical Outcomes Confirms DaVitas Leadership Position on Quality Dialysis Care
9. Increasing Sales Productivity Through Superior Sales Force Performance Management
10. By adding graphene, researchers create superior polymer
11. Flurizans Effect in Delaying Progression From Mild Cognitive Impairment to Alzheimers Disease is Superior to That of Aricept
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... December 06, 2016 , ... RoviSys, a leading ... in Aurora, Ohio, announced the opening of their new office building today. Located ... facility is home to 200 employees focused on providing sales, engineering, and support ...
(Date:12/5/2016)... ... December 05, 2016 , ... The Real Dirt ... premier cannabis technology and application experts, Chip Baker. Chip Baker formerly co-founded Royal ... the past 30 years, Chip Baker other industry veterans have made the evolution ...
(Date:12/5/2016)... CALGARY , Dec. 5, 2016 /PRNewswire/ - ... announced  that the independent Data and Safety Monitoring ... trial in high-risk cardiovascular disease (CVD) patients has ... that the study should continue as planned without ... and noted that no safety or efficacy concerns ...
(Date:12/5/2016)... , December 5, 2016 The ... with almost $108 billion of revenue and some $890 ... were spent on global biopharmaceuticals, and this figure is ... Stock-Callers.com has lined up these four equities for assessment: ... Pharmaceuticals Inc. (NASDAQ: ACAD ), Acorda Therapeutics ...
Breaking Biology Technology:
(Date:11/22/2016)... MINNETONKA, Minn. , Nov. 22, 2016   ... that supports the entire spectrum of clinical research, is ... by Medical LiveWire Healthcare and Life Sciences Awards ... This award caps off an unprecedented year of recognition ... clinical trials for over 15 years. iMedNet ...
(Date:11/17/2016)... Global Market Watch: Primarily supported by ownership types; ... Academics) market is to witness a value of US$37.1 billion ... Compounded Annual Growth Rate (CAGR) of 10.75% is foreseen from ... 2014-2020. North America is not way ... Europe at 9.56% respectively. Report Focus: ...
(Date:11/15/2016)...  Synthetic Biologics, Inc. (NYSE MKT: SYN), a ... gut microbiome, today announced the pricing of an ... common stock and warrants to purchase 50,000,000 shares ... the public of $1.00 per share and accompanying ... offering, excluding the proceeds, if any from the ...
Breaking Biology News(10 mins):